Callan Family Office’s Vicor VICR Stock Holding History

Callan Family Office’s Portfolio VICR Stock Details VICR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$201K	Buy	+530	New	+$145K	﹤0.01%	1154

Other funds holding VICR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Callan Family Office's VICR Position: Q2 2026 in Review

Callan Family Office opened a new position in Vicor (VICR) in Q2 2026: 530 shares worth $201K. The stake represents ﹤0.01% of the portfolio and ranks #1154 among its holdings.

514 funds tracked by Wall St. Rank hold VICR as of Q2 2026.

Callan Family Office held 530 shares of Vicor worth $201K as of Q2 2026.
Vicor was a new Callan Family Office position in Q2 2026.
Vicor made up ﹤0.01% of Callan Family Office's portfolio in Q2 2026, its #1154 holding.
514 funds tracked by Wall St. Rank held Vicor as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.